現代牙科(03600.HK)年度純利大增82.4%至4.02億港元 末期息每股9港仙
格隆匯3月26日丨現代牙科(03600.HK)公佈年度業績,截至2023年12月31日止年度,年度收入約為31.72億港元,同比增加約12.1%。年度毛利約為17.01億港元,同比增加約22.9%,毛利率升至53.6%;EBITDA約為6.94億港元,同比增加約49.9%;純利約為4.02億港元,同比增加約82.4%,每股基本盈利為42.4港仙,擬派末期股息每股9.0港仙。
截至2023年12月31日止年度,集團於中國內地生產廠房生產之數碼化解決方案個案(海外及國內)(為免生歧義,不包括於集團非中國內地生產廠房或海外╱衞星牙科實驗室生產之數碼化解決方案個案)增加至約857,064件,較2022年同期(約549,736件)增加55.9%,原因為更多客户採用口腔內部掃描儀。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.